CellGenic offers both individual vials and pre-formulated combination products for multi-pathway research
Mikus D, Sikiric P, Seiwerth S, Petricevic A, Aralica G, Druzijanic N, Rucman R, Petek M, Pigac B, Perovic D, Kolombo M, Kokic N, Mikus S, Duplancic B, Fattorini I, Turkovic B, Rotkvic I, Mise S, Prkacin I, Konjevoda P, et al
A 2016 review by Sikiric and colleagues in Current Neuropharmacology framed BPC-157's effects within a brain-gut axis model, while a 2024 review by Sikiric and colleagues in Pharmaceuticals (Basel) examined the peptide's relationships with multiple neurotransmitter systems
There was less edema observed and lower levels of inflammatory cells present
Two components contribute to CAI
Will Medicare pay for B12 shots